A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers
Condition: HER2-amplified Biliary Tract Cancers Interventions: Drug: ZW25 (Zanidatamab); Diagnostic Test: In situ hybridization (ISH)-based companion diagnostic assay; Diagnostic Test: Immunohistochemistry (IHC)-based companion diagnostic assay Sponsors: Zymeworks Inc.; BeiGene, Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials